image
Healthcare - Biotechnology - NASDAQ - US
$ 0.211
-12.4 %
$ 3.91 M
Market Cap
-0.02
P/E
BALANCE SHEET
24.8 M ASSETS
-27.39%
12.6 M LIABILITIES
-22.29%
12.2 M EQUITY
-32.01%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Aptevo Therapeutics Inc.
image
Current Assets 19.1 M
Cash & Short-Term Investments 16.9 M
Receivables 0
Other Current Assets 2.16 M
Non-Current Assets 5.78 M
Long-Term Investments 0
PP&E 5.78 M
Other Non-Current Assets 0
Current Liabilities 7.22 M
Accounts Payable 3.98 M
Short-Term Debt 0
Other Current Liabilities 3.24 M
Non-Current Liabilities 5.4 M
Long-Term Debt 5.4 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014
ASSETS
Cash & Cash Equivalents 16.9 22.6 45.0 40.0 12.4 30.6 7.1 9.7 4.6 3.6
Short Term Investments 0 0 0 0 0 0 73.7 44.8 0 0
Receivables 0 2.5 3.7 2.4 0 5.2 2.1 0.3 7.8 15.1
Inventory 0 1.6 3.1 4.8 6.1 1.8 1.0 6.6 20.3 17.6
Other Current Assets 2.2 2.3 3.9 4.9 11.4 11.0 11.1 16.1 2.3 5.2
Total Current Assets 19.1 27.4 52.6 47.3 30.0 48.7 95.1 71.4 35.1 41.6
PP&E 5.8 6.8 4.0 5.5 7.7 5.2 5.8 5.9 4.2 3.2
Intangible Assets 0 0 0 0 4.4 5.2 6.1 14.5 59.2 61.3
Goodwill 0 0 0 0 0 0 0 0 13.9 13.9
Long Term Investments 0 0 0 0 7.5 7.4 (17.4) 0 0 0
Other Long Term Assets 0 (6.8) 68 K 0.7 11.3 8.4 10.0 0 (2.9) 0
Other Assets 0 0 0 0 0 0 0 0 0 0
Total Assets 24.8 34.2 56.6 53.5 53.4 67.5 117.0 91.9 112.5 120.0
LIABILITIES
Accounts Payable 4.0 3.5 3.5 5.6 6.4 11.7 7.3 10.5 10.1 11.5
Short Term Debt 0 2.0 11.7 5.0 19.9 0 3.3 0 0 0
Other Current Liabilities 3.2 3.2 19.6 4.0 11.9 5.9 7.8 8.2 6.0 7.5
Total Current Liabilities 7.2 8.7 34.8 14.5 38.2 17.6 18.5 19.5 19.9 19.8
Long Term Debt 5.4 7.5 5.0 22.4 3.3 19.3 15.7 18.4 0 0
Deferred Tax Income 0 0 0 0 0 0 (0.2) 0 0.5 1.9
Other Liabilities 0 0 15.6 0 0 0.2 0.7 0.5 71 K 0
Total Liabilities 12.6 16.2 55.4 37.0 41.6 37.1 35.0 41.3 23.8 25.4
EQUITY
Common Stock 61 K 48 K 47 K 46 K 45 K 23 K 22 K 20 K 320.6 267.3
Retained Earnings (223.4) (206.0) (214.1) (185.6) (167.9) (127.4) (73.7) (80.7) (232.0) (172.7)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 (0.1) 33 K (5.9) (5.3)
Total Equity 12.2 18.0 1.2 16.6 11.8 30.4 82.0 50.6 88.6 94.6
Total Liabilities and Equity 24.8 34.2 56.6 53.5 53.4 67.5 117.0 91.9 112.5 120.0
SHARES OUTSTANDING
Common Shares Outstanding 0.3 0.1 0.1 77.1 K 66.3 K 36.5 K 34.6 K 32.9 K 32.8 K 32.8 K 32.8 K